Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 09/30 04:00:08 pm
112.31 USD   -1.40%
7d ago Wall St. rallies, S&P back above 14-day moving average
09/19 NASDAQ 100 MOVERS : Mu, amzn
09/12 NASDAQ 100 MOVERS : Vrtx, yhoo
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS : Assigned Patent
7d ago Wall St. rallies, S&P back above 14-day moving average
09/19 NASDAQ 100 MOVERS : Mu, amzn
09/16 VERTEX PHARMACEUTICALS : Assigned Patent
09/12 NASDAQ 100 MOVERS : Vrtx, yhoo
09/11 S&P 500 rebounds with energy shares; Dow dips
09/11 VERTEX PHARMACEUTICALS : Analyst Scanner on Biotech Equities - Prana Biotechnolo..
09/10 VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Global Healthcare Conf..
09/08 VERTEX PHARMACEUTICALS : Announces Upcoming Presentations of Data at North Ameri..
09/07 VERTEX PHARMACEUTICALS : to Speak at the Morgan Stanley Global Healthcare Confer..
09/05 VERTEX PHARMACEUTICALS : S&P 500 Movers: KORS, VRTX
09/05 NASDAQ 100 MOVERS : Gild, vrtx
09/05 VERTEX PHARMACEUTICALS : to Speak at the Morgan Stanley Global Healthcare Confer..
09/04 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Thiophene Compo..
09/04 VERTEX PHARMACEUTICALS : Patent Issued for Processes for Producing Cycloalkylcar..
09/02 VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Global Healthcare Conf..
08/28 VERTEX PHARMACEUTICALS : Saskatchewan to cover expensive cystic fibrosis drug
08/28 NASDAQ 100 MOVERS : Vip, vrtx
08/22 VERTEX PHARMACEUTICALS : Assigned Patent
08/20 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Solid Forms of ..
08/20 VERTEX PHARMACEUTICALS : Patent Issued for Isothiazolopyridinones Useful for the..
08/15 VERTEX PHARMACEUTICALS : Assigned Patent
08/13 Biotechs lift Wall Street; Dow back in black for 2014
08/13DJMARKET SNAPSHOT : U.S. Stocks Push Higher; Biotechs Rally
08/13 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry Described by Invest..
08/11 S&P 500 MOVERS : Vrtx, kmi
08/11 NASDAQ 100 MOVERS : Ilmn, tsla
08/08 VERTEX PHARMACEUTICALS : Assigned Patent
08/06 VERTEX PHARMACEUTICALS : Receives European Approval for KALYDECO™ ivacafto..
08/06 VERTEX PHARMACEUTICALS : Patent Application Titled "Dosage Units of 3-(6-(1-(2,2..
07/31 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
07/31 VERTEX PHARMACEUTICALS : Receives European Approval for KALYDECO™ (ivacaft..
07/31 VERTEX PHARMACEUTICALS : Patent Issued for Thiazoles and Pyrazoles Useful as Kin..
07/31 VERTEX PHARMACEUTICALS : Patent Application Titled "Methods for Amplifying Hepat..
07/30 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of N--1,4-Dihydro-4-Oxoqu..
07/30 NASDAQ 100 MOVERS : Grmn, regn
07/29 VERTEX PHARMACEUTICALS : Pharma posts bigger 2Q loss
07/29 VERTEX PHARMACEUTICALS : Reports Second Quarter 2014 Financial Results and Provi..
07/28 Pfizer's need for deal looms larger with earnings report
07/25 VERTEX PHARMACEUTICALS : MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investor..
07/25 VERTEX PHARMACEUTICALS : Assigned Patent
07/23 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Ju..
07/23 VERTEX PHARMACEUTICALS : Patent Issued for Processes for Preparing Substituted P..
07/23 VERTEX PHARMACEUTICALS : INVESTOR ALERT: Class Action Lawsuit Against Vertex Pha..
07/23 VERTEX PHARMACEUTICALS : Peter Mueller, Ph.D to Retire from Vertex Pharmaceutica..
07/18 VERTEX PHARMACEUTICALS : Assigned Patent
07/16 VERTEX PHARMACEUTICALS : Announces Retirement of Peter Mueller, Ph.D.
07/16 VERTEX PHARMACEUTICALS : Peter Mueller, Ph.D to Retire from Vertex Pharmaceutica..
07/15 VERTEX PHARMACEUTICALS : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds In..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Ju..
07/14 NASDAQ 100 MOVERS : Vrtx, myl
07/14 VERTEX PHARMACEUTICALS : House Energy and Commerce Subcommittee on Health Hearin..
07/11 VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
07/10 VERTEX PHARMACEUTICALS : Announces Retirement of Peter Mueller, Ph.D.
07/09 VERTEX PHARMACEUTICALS : Receives European CHMP Positive Opinion for KALYDECO&tr..
07/09 VERTEX PHARMACEUTICALS : Faruqi & Faruqi, LLP Encourages Investors Who Suffered ..
07/09 VERTEX PHARMACEUTICALS : Submits Supplemental New Drug Application sNDA to U.S. ..
07/08 VERTEX PHARMACEUTICALS : Files sNDA for Kalydeco (ivacaftor)
07/07 VERTEX PHARMACEUTICALS : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Invest..
07/03 VERTEX PHARMACEUTICALS : Files Supplemental New Drug Application for Kalydeco (i..
07/02 VERTEX PHARMACEUTICALS : Patent Issued for Co-Crystals and Pharmaceutical Compos..
07/02 VERTEX PHARMACEUTICALS : Ahead of the Bell: Vertex soars on study
07/02 VERTEX PHARMACEUTICALS : Patent Issued for Thiophene-Carboxamides Useful as Inhi..
07/02 VERTEX PHARMACEUTICALS : Cystic Fibrosis Foundation Applauds Successful Phase 3 ..
07/01 VERTEX PHARMACEUTICALS : INVESTOR ALERT: Class Action Lawsuit Against Vertex Pha..
06/30 VERTEX PHARMACEUTICALS : Submits Supplemental New Drug Application (sNDA) to U.S..
06/27 VERTEX PHARMACEUTICALS : Faruqi & Faruqi, LLP : Encourages Investors Who Suffere..
06/27 VERTEX PHARMACEUTICALS : Receives European CHMP Positive Opinion for KALYDECO&tr..
06/27 VERTEX PHARMACEUTICALS : Biotech Stocks on the Move -- Research on CTI BioPharma..
06/26 VERTEX PHARMACEUTICALS : Licenses VX-787 to Janssen Pharmaceuticals for the Trea..
06/26 VERTEX PHARMACEUTICALS : Announces a Signed Letter of Intent to Enable Public Re..
06/26 VERTEX PHARMACEUTICALS : INVESTOR ALERT: Investigation of Vertex Pharmaceuticals..
06/26 VERTEX PHARMACEUTICALS : Updates on Licensing of VX-787 to Janssen Pharmaceutica..
06/26 VERTEX PHARMACEUTICALS : Enters into Licenses Pact with Janssen
06/25 VERTEX PHARMACEUTICALS : Biotech R&D and Clinical Trials Lead To Potential Reven..
1  2  3  4  5  6  7  8Next
Advertisement
Chart
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF